Dyonne Y. Vos, Bart van de Sluis

Background: Metabolic-associated fattyliverdisease (MAFLD), also known as non-alcoholic fatty liver disease, has become the leading cause of chronic liver disease worldwide. In addition to hepatic accumulation of triglycerides, dysregulated cholesterol metabolism is [read more…]